NIRAPARIB WITH ABIRATERONE ACETATE AND PREDNISONE FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE PHASE 2 QUEST STUDY

被引：0
|
作者：
Chi, Kim
Fleshner, Neil
Chiuri, Vincenzo Emanuele
Van Bruwaene, Siska
Hafron, Jason
McNeel, Douglas G.
De Porre, Peter
Maul, R. Scott
Daksh, Mahesh
Zhong, Xiaogang
Mason, Gary E.
Tutrone, Ronald
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP27-17
引用
收藏
页码：E456 / E457
页数：2
相关论文
共 50 条
  • [31] Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer
    Mohamed Salem
    Jorge A. Garcia
    Current Oncology Reports, 2011, 13 : 92 - 96
  • [32] Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Lily P. H. Yang
    Katherine A. Lyseng-Williamson
    Drugs & Aging, 2012, 29 : 243 - 248
  • [33] New drugs in the treatment of metastatic castration-resistant prostate cancer: abiraterone acetate
    Martinez-Hernandez, Lucia
    Martinez-Prieto, Marcela
    Galvan-Salazar, Gabriel
    GACETA MEXICANA DE ONCOLOGIA, 2013, 12 (01): : 32 - 40
  • [34] The development of abiraterone acetate for castration-resistant prostate cancer
    Grist, Emily
    Attard, Gerhardt
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (06) : 289 - 294
  • [35] Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer
    Scott, Lesley J.
    Yang, Lily P. H.
    Lyseng-Williamson, Katherine A.
    DRUGS & AGING, 2012, 29 (03) : 243 - 248
  • [36] Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prostate cancer
    Martini, Alberto
    Fallara, Giuseppe
    Ploussard, Guillaume
    Malavaud, Bernard
    LANCET ONCOLOGY, 2023, 24 (10): : 1056 - 1057
  • [37] Clinical Experience of Steroid Switch from Prednisone to Dexamethasone in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
    Fang, Wan-Yun
    Wang, Pai-Fu
    Fan, Yen-Chun
    Shih, Hung-Jen
    UROLOGIA INTERNATIONALIS, 2021, 105 (5-6) : 380 - 385
  • [38] A phase I study of capivasertib in combination with abiraterone acetate in patients with metastatic castration-resistant prostate cancer.
    Shore, Neal D.
    Mellado, Begona
    Shah, Satish
    Hauke, Ralph J.
    Costin, Dan
    Morris, Thomas
    Anjum, Rana
    Szijgyarto, Zsolt
    Verheijen, Remy B.
    Cullberg, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [39] Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study
    Thiery-Vuillemin, Antoine
    Poulsen, Mads Hvid
    Lagneau, Edouard
    Ploussard, Guillaume
    Birtle, Alison
    Dourthe, Louis-Marie
    Beal-Ardisson, Dominique
    Pintus, Elias
    Trepiakas, Redas
    Antoni, Laurent
    Lukac, Martin
    Van Sanden, Suzy
    Pissart, Genevieve
    Reid, Alison
    ESMO OPEN, 2018, 3 (05)
  • [40] Abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Mostaghel, Elahe A.
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 39 - 51
12345